HARMONY BIOSCIENCES TO PARTICIPATE IN OPPENHEIMER MOVERS IN RARE DISEASE SUMMIT

Rhea-AI Summary

Harmony Biosciences (Nasdaq: HRMY) has announced its participation in the Oppenheimer Movers in Rare Disease Summit in New York. The company's management team will engage in a fireside chat scheduled for Thursday, December 12, 2024, at 9:00 a.m. ET. Interested parties can access a webcast of the discussion through the investor relations section of Harmony's website.

News Market Reaction – HRMY

-1.79%

-1.79% Session move

In the trading session that priced this news, HRMY declined 1.79%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PLYMOUTH MEETING, Pa., Dec. 3, 2024 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony's management team will participate in a fireside chat at the upcoming Oppenheimer Movers in Rare Disease Summit in New York, NY on Thursday, December 12, 2024, at 9:00 a.m. ET.

A webcast of the fireside chat will be available on the investor page of Harmony's website at https://ir.harmonybiosciences.com/.

About Harmony Biosciences
Harmony Biosciences is a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases who have unmet medical needs. Driven by novel science, visionary thinking, and a commitment to those who feel overlooked, Harmony Biosciences is nurturing a future full of therapeutic possibilities that may enable patients with rare neurological diseases to truly thrive. Established by Paragon Biosciences, LLC, in 2017 and headquartered in Plymouth Meeting, Pa, we believe that when empathy and innovation meet, a better future can begin; a vision evident in the therapeutic innovations we advance, the culture we cultivate, and the community programs we foster. For more information, please visit www.harmonybiosciences.com.

Harmony Biosciences Investor Contact:
Brennan Doyle
484-539-9700
bdoyle@harmonybiosciences.com

Harmony Biosciences Media Contact:
Cate McCanless
202-641-6086
cmccanless@harmonybiosciences.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/harmony-biosciences-to-participate-in-oppenheimer-movers-in-rare-disease-summit-302320185.html

SOURCE Harmony Biosciences

FAQ

When is Harmony Biosciences (HRMY) presenting at the Oppenheimer Rare Disease Summit 2024?

Harmony Biosciences will present at the Oppenheimer Movers in Rare Disease Summit on Thursday, December 12, 2024, at 9:00 a.m. ET in New York.

How can investors watch Harmony Biosciences' (HRMY) Oppenheimer Summit presentation?

Investors can watch the webcast of Harmony Biosciences' fireside chat through the investor relations page at https://ir.harmonybiosciences.com/.

What type of presentation will Harmony Biosciences (HRMY) give at the Oppenheimer Summit?

Harmony Biosciences will participate in a fireside chat format presentation at the Oppenheimer Movers in Rare Disease Summit.

Where is the Oppenheimer Rare Disease Summit 2024 with Harmony Biosciences (HRMY) being held?

The Oppenheimer Movers in Rare Disease Summit is being held in New York, NY.